Skip to main content

International Symposium
on HPV Infection in
Head and Neck Cancer


The HPV has been identified as the causative factor for the subset of head and neck cancer and for a last decades the constant increase of incidence of HPV positive cancer patients in Europe has been observed. The discussion about the treatment and outcome of these patients is one of the most up to date problems in head and neck oncology.

Furthermore, infections with cancer-causing human papillomaviruses (HPV) are becoming more and more common among patients.

During the symposium the most renowned experts in the field of surgery, radiotherapy, medical oncology, immunology and basic biology will exchange their knowledge and experience during challenging sessions and debates.

  • 5th International:
  • 4th International:

    10-11 November 2022, Amsterdam - the Netherlands

  • 3rd Symposium:

    January 25-28, 2018 in Essen (Germany)

  • 2nd Symposium:

    November 3-4, 2016 in Leipzig (Germany)

  • 1st Symposium:

    November 13-14, 2014 in Poznań (Poland)